Variation of serum hepatic enzymes, bilirubinemia during the use of RH in the treatment of pulmonary TB
- Author:
Vu Quang Dien
- Publication Type:Journal Article
- Keywords:
Pulmonary tuberculosis
- MeSH:
Tuberculosis, Pulmonary;
Hyperbilirubinemia;
Liver;
Therapeutics
- From:Journal of Medical and Pharmaceutical Information
2003;2():34-37
- CountryViet Nam
- Language:Vietnamese
-
Abstract:
The prospective study was carried out at Phuc Yen Hospital of tuberculosis and lung diseases from March 2000 to March 2001, on 60 patients with newly acquired AFB (+) tuberculosis. 30 patients of control group were treated by 2 SHRZ/6HE procedure, and 30 of studied group by 2SHRZ/4RH. Danan method (1992) give results that: SGOT, SGPT, bilirubin of the two groups directly increased after first month use of medication, with significantly statistic difference, as comparing before treatment, and returned to normal in 2nd month. SGPT, bilirubin directly increased 2N in 2 groups occurred mainly after the first month. No clinical sign of hepatitis was noted. Between the 2 groups there was not significant variation of liver enzym and bilirubin during the treatment course
